Massachusetts Financial Services
GTHX

Massachusetts Financial Services’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Massachusetts Financial Services’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-39,401
Closed -$529K – 952
2021
Q3 		$529K Sell
39,401
-517
-1% -$8.43K ﹤0.01% 871
2021
Q2 		$876K Buy
39,918
+342
+0.9% +$7.6K ﹤0.01% 851
2021
Q1 		$952K Sell
39,576
-15,332
-28% -$356K ﹤0.01% 841
2020
Q4 		$988K Sell
54,908
-550
-1% -$8.22K ﹤0.01% 794
2020
Q3 		$641K Buy
+55,458
New +$915K ﹤0.01% 809

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Massachusetts Financial Services's GTHX Position: Q4 2021 in Review

Massachusetts Financial Services sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q4 2021, closing a stake of 39,401 shares — an estimated $529K sold.

Massachusetts Financial Services first reported a position in GTHX in Q3 2020 and held it in 5 quarters. The position peaked at $988K in Q4 2020. 108 funds tracked by Wall St. Rank hold GTHX as of Q4 2021.

  • Massachusetts Financial Services reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Massachusetts Financial Services sold 39,401 G1 Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $529K.
  • Massachusetts Financial Services first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2020 and held it in 5 quarters.
  • Massachusetts Financial Services's G1 Therapeutics, Inc. Common Stock position peaked at $988K in Q4 2020.
  • 108 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Massachusetts Financial Services's 13F filing for Q4 2021, filed 10 Feb 2022.